Evaluation of the prognostic utility of the hemoglobin-to-red cell distribution width ratio in head and neck cancer.

Tristan ThamCaitlin OlsonMichael WotmanSireesha TeegalaJulian KhaymovichJosephine CouryPeter Costantino

Published in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2018)

A low Hb/RDW ratio was associated with poorer EFS (HR = 2.02, 95% CI 1.13-3.61, p = 0.017), but was not associated with OS. This is the first study reporting the prognostic utility of Hb:RDW in head and neck cancer.

Keyphrases

single cell
cell therapy
stem cells
adverse drug
mesenchymal stem cells
electronic health record